Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
7.86% | 0 | 54.88% | 2.55% | 2050-11-13 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
7.11% | 0 | 67.29% | 3.90% | 2062-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
7.10% | 0 | 68.54% | 3.70% | 2052-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.95% | 0 | 65.55% | 2.35% | 2040-11-13 | 750 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.82% | 158 K | 71.63% | 3.25% | 2042-08-01 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.81% | 0 | 74.38% | 3.55% | 2042-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560589Celgene Corporation 4.35% 15-NOV-2047 | 6.73% | 10 K | 78.64% | 4.35% | 2047-11-15 | 13.57 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.60% | 26.78 M | 77.97% | 4.25% | 2049-10-26 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.58% | 1.66 M | 79.76% | 4.35% | 2047-11-15 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.55% | 40 K | 104.10% | 6.88% | 2097-08-01 | 62.42 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
6.44% | 12 M | 82.50% | 4.55% | 2048-02-20 | 1.24 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4036425Celgene Corporation 5.25% 15-AUG-2043 | 6.40% | 65 K | 90.24% | 5.25% | 2043-08-15 | 4.06 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
BBMY4124214Celgene Corporation 4.625% 15-MAY-2044 | 6.38% | 20 K | 84.86% | 4.63% | 2044-05-15 | 3.69 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.28% | 0 | 84.60% | 4.50% | 2044-03-01 | 341.52 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.26% | 0 | 93.06% | 5.65% | 2064-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.24% | 2.7 M | 85.90% | 4.63% | 2044-05-15 | 744.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.20% | 0 | 102.22% | 6.40% | 2063-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597874Celgene Corporation 4.55% 20-FEB-2048 | 6.19% | 20 K | 84.30% | 4.55% | 2048-02-20 | 37.2 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.17% | 0 | 93.56% | 5.55% | 2054-02-22 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.17% | 125 K | 89.45% | 5.00% | 2045-08-15 | 741.72 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.14% | 10 M | 84.72% | 4.13% | 2039-06-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
6.12% | 0 | 101.37% | 6.25% | 2053-11-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4275603Celgene Corporation 5.0% 15-AUG-2045 | 6.12% | 134 K | 89.87% | 5.00% | 2045-08-15 | 15.71 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
6.07% | 0 | 95.00% | 5.50% | 2044-02-22 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY3685700Celgene Corporation 5.7% 15-OCT-2040 | 5.98% | 290 K | 97.64% | 5.70% | 2040-10-15 | 2.3 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
5.95% | 4 K | 97.96% | 5.70% | 2040-10-15 | 151.01 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.80% | 20 K | 99.34% | 3.88% | 2025-08-15 | 228.73 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.53% | 0 | 87.07% | 2.95% | 2032-03-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.38% | 0 | 103.53% | 5.88% | 2036-11-15 | 279.22 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.30% | 0 | 99.40% | 5.20% | 2034-02-22 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.29% | 0 | 103.59% | 5.90% | 2033-11-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.26% | 30 K | 106.69% | 6.13% | 2038-05-01 | 219.25 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.15% | 1.42 M | 83.93% | 1.45% | 2030-11-13 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
5.09% | 50 K | 101.48% | 5.25% | 2043-08-15 | 218.37 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.88% | 0 | 103.94% | 5.75% | 2031-02-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.85% | 403 K | 94.84% | 3.40% | 2029-07-26 | 2.37 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4597873Celgene Corporation 3.9% 20-FEB-2028 | 4.79% | 92 K | 97.77% | 3.90% | 2028-02-20 | 43.84 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
4.78% | 0 | 101.46% | 5.10% | 2031-02-22 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
BBMY4560450Celgene Corporation 3.45% 15-NOV-2027 | 4.77% | 5 K | 96.92% | 3.45% | 2027-11-15 | 16.55 M USD | 1,000.00 USD | 2,000.00 USD | Celgene Corp. |
4.65% | 0 | 100.82% | 4.90% | 2029-02-22 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.60% | 750 K | 95.71% | 3.40% | 2029-07-26 | 26.56 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.57% | 15.18 M | 100.23% | 4.84% | 2026-02-20 | 500 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.56% | 86 K | 97.42% | 3.45% | 2027-11-15 | 517.67 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.55% | 235 K | 98.35% | 3.90% | 2028-02-20 | 1.45 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.54% | 0 | 100.34% | 4.95% | 2026-02-20 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.53% | 0 | 97.78% | 3.25% | 2027-02-27 | 512.28 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.52% | 1.03 M | 97.83% | 0.75% | 2025-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.48% | 2.3 M | 98.57% | 3.20% | 2026-06-15 | 1.74 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.43% | 0 | 92.32% | 1.13% | 2027-11-13 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.32% | 0 | 101.01% | 4.90% | 2027-02-22 | 1 B USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
4.19% | 262 K | 103.93% | 6.80% | 2026-11-15 | 255.95 M USD | 1,000.00 USD | 1,000.00 USD | Bristol Myers Squibb Co. | |
3.71% | 0 | 85.61% | 1.75% | 2035-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
2.72% | 0 | 99.84% | 1.00% | 2025-05-15 | 575 M EUR | 1,000.00 EUR | 100,000.00 EUR | Bristol Myers Squibb Co. | |
2.47% | 0 | 130.24% | 4.25% | 2049-10-26 | 500 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.39% | 0 | 122.76% | 4.13% | 2039-06-15 | 4.4 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.35% | 0 | 141.76% | 5.00% | 2045-08-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.32% | 0 | 137.60% | 4.55% | 2048-02-20 | 9.5 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
2.27% | 0 | 104.25% | 3.20% | 2026-06-15 | 5.95 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
1.47% | 0 | 116.80% | 3.90% | 2028-02-20 | 6.07 M USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. | |
1.28% | 0 | 114.77% | 3.45% | 2027-11-15 | 67 K USD | 1,000.00 USD | 2,000.00 USD | Bristol Myers Squibb Co. |